Company profile for Nerviano Medical Sciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nerviano Medical Sciences S.r.l is focused on discovery and clinical development of small molecule NCEs for oncology. The company takes innovative approaches on novel mechanisms of action and drug targets to bring first- and best-in-class personalized medicines to cancer patients. Our current pipeline consists of NCEs, which all originate from our well validated oncology drug discovery platform that span from early preclinica...
Nerviano Medical Sciences S.r.l is focused on discovery and clinical development of small molecule NCEs for oncology. The company takes innovative approaches on novel mechanisms of action and drug targets to bring first- and best-in-class personalized medicines to cancer patients. Our current pipeline consists of NCEs, which all originate from our well validated oncology drug discovery platform that span from early preclinical to clinical stage projects and which are being developed both in house and with partners.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Viale Pasteur 10 – CP11 20014 – Nerviano (Milano)
Telephone
Telephone
+39.0331.581111
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20231214543204/en

BUSINESSWIRE
14 Dec 2023

https://www.businesswire.com/news/home/20231012222203/en

BUSINESSWIRE
12 Oct 2023

https://www.businesswire.com/news/home/20231002835954/en

BUSINESSWIRE
02 Oct 2023

https://www.businesswire.com/news/home/20230801161697/en

BUSINESSWIRE
01 Aug 2023

https://www.prnewswire.com/news-releases/nerviano-medical-sciences-announces-licensing-of-linker-payload-technology-to-solve-therapeutics-to-develop-and-commercialize-novel-antibody-drug-conjugates-301842458.html

PR NEWSWIRE
05 Jun 2023

https://www.businesswire.com/news/home/20230112005903/en

BUSINESSWIRE
12 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty